Newborns can now be screened for muscular dystrophy with a simpler test

US health regulators are making it easier to get new tests for muscular dystrophy approved. They are moving these tests into a category that requires less regulatory review. This means new screening tests for newborns can reach the market faster, potentially improving early diagnosis.

For years, new medical devices faced a long, expensive approval process, even for relatively straightforward tests. This change means that a specific type of diagnostic test, for muscular dystrophy, can now get to patients more quickly. It sets a precedent for how US health regulators might handle other newborn screening tests, potentially speeding up access to early detection for other conditions.